成都青山利康药业

Chengdu Qingshan Likang Pharmaceutical is a prominent Chinese pharmaceutical company focused on the fields of nephrology, anesthesiology, and clinical nutrition. Established in 2001 and headquartered in Chengdu, the company has become a leading domestic provider of hemodialysis and peritoneal dialysis products, serving a large population of patients with chronic kidney disease. Its product portfolio includes a wide range of dialysis concentrates, solutions, and specialized anesthetic agents such as propofol injectable emulsions. As a key member of the Kelun Pharmaceutical Group, Qingshan Likang operates advanced manufacturing facilities that comply with national GMP standards. The company continues to expand its presence in the critical care and parenteral nutrition markets through the development of high-quality generic and value-added therapeutic products.